MoneyWorks4Me

Dr Reddys Laboratories board recommends Final Dividend

13 May 2014 Evaluate

Dr Reddys Laboratories has informed that the Board of Directors of the company at its meeting held on May 13, 2014 have recommended a final dividend of Rs 18 (360%) per equity share of Rs 5 face value, for the financial year 2013-14. The dividend on equity shares, If declared by the shareholders at the ensuing Annual General Meeting, will be credited / despatched on or after August 07, 2014.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.95
Dr. Reddys Labs. 1146.25
Cipla 1355.90
Lupin 2055.30
Zydus Lifesciences 1104.95
View more..